These results indicate that SF-1 might be a co-regulator of energy balance and that mutations in SF-1 may therefore also lead to metabolic consequences (e.g. obesity) in humans. This evidence concerns the gene SF1 and obesity due to melanocortin 4 receptor deficiency.